Viridian Therapeutics, Inc./DE (VRDN) Net margin 2016–2025
Viridian Therapeutics, Inc./DE (VRDN) net profit margin by fiscal year — reported net income divided by reported revenue.
-483.6%FY2025 · since FY2016: -496.8% → -483.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -483.6% | +88903.5 pp |
| FY2024 | -89387.1% | -13675.6 pp |
| FY2023 | -75711.5% | -68382.2 pp |
| FY2022 | -7329.2% | -4649.1 pp |
| FY2021 | -2680.2% | +7864.1 pp |
| FY2020 | -10544.3% | -9605.6 pp |
| FY2019 | -938.6% | -548.7 pp |
| FY2018 | -390.0% | +272.3 pp |
| FY2017 | -662.3% | -165.5 pp |
| FY2016 | -496.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice